Publications
Journal Article (99)
1.
Journal Article
39 (4), pp. 321 - 328 (2024)
Novel multifunctional nanoliposomes inhibit α-synuclein fibrillization, attenuate microglial activation, and silence the expression of SNCA gene. Neurología (English Edition) 2.
Journal Article
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice. Movement Disorders (2024)
3.
Journal Article
Adsorption of alpha-synuclein and inhibition of fibril formation by nanocellulose and gold-coated-nanocellulose. Cellulose (2024)
4.
Journal Article
Altered hippocampal doublecortin expression in Parkinson's disease. Journal of Neurochemistry (2024)
5.
Journal Article
22, pp. 2670 - 2676 (2024)
Chemical synthesis of site-selective advanced glycation end products in α-synuclein and its fragments. Organic & Biomolecular Chemistry 6.
Journal Article
125 (3), e30523 (2024)
In silico analysis of alpha‐synuclein protein variants and posttranslational modifications related to Parkinson's disease. Journal of Cellular Biochemistry 7.
Journal Article
Inhibition of 26S proteasome activity by α-synuclein is mediated by the proteasomal chaperone Rpn14/PAAF1. Aging Cell (2024)
8.
Journal Article
121 (2), e2309700120 (2024)
Substitution of Met-38 to Ile in γ-synuclein found in two patients with amyotrophic lateral sclerosis induces aggregation into amyloid. PNAS 9.
Journal Article
13 (1), e6900 (2024)
Uncovering potential diagnostic and pathophysiological roles of α-synuclein and DJ-1 in melanoma. Cancer Medicine 10.
Journal Article
147 (1), pp. 81 - 90 (2024)
Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathies. Brain 11.
Journal Article
147 (1), 40 (2024)
Regional AT-8 reactive tau species correlate with intracellular Aβ levels in cases of low AD neuropathologic change. Acta Neuropathologica 12.
Journal Article
1869 (8), 166835 (2023)
Glycation modulates superoxide dismutase 1 aggregation and toxicity in models of sporadic amyotrophic lateral sclerosis. Biochimica et Biophysica Acta-Molecular Basis of Disease 13.
Journal Article
PrP meets alpha-synuclein: Molecular mechanisms and implications for disease. Journal of Neurochemistry (2023)
14.
Journal Article
146, pp. 369 - 385 (2023)
More than meets the eye in Parkinson’s disease and other synucleinopathies: from proteinopathy to lipidopathy. Acta Neuropathologica 15.
Journal Article
166 (5), pp. 862 - 874 (2023)
Proteomic analysis of the human hippocampus identifies neuronal pentraxin 1 (NPTX1) as synapto-axonal target in late-stage Parkinson's disease. Journal of Neurochemistry 16.
Journal Article
38 (9), pp. 1585 - 1597 (2023)
Extracellular Vesicles for the Diagnosis of Parkinson's Disease: Systematic Review and Meta-Analysis. Movement Disorders 17.
Journal Article
24 (17), 13435 (2023)
Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s Disease. International Journal of Molecular Sciences 18.
Journal Article
29 (1), 111 (2023)
The alpha-synuclein oligomers activate nuclear factor of activated T-cell (NFAT) modulating synaptic homeostasis and apoptosis. Molecular Medicine 19.
Journal Article
39 (4-6), pp. 321 - 335 (2023)
Uncovering the Molecular Link Between Lead Toxicity and Parkinson's Disease. Antioxidants & redox signaling 20.
Journal Article
19 (8), pp. 453 - 454 (2023)
AI and protein structure and function in neurological disease: relevance to disease management. Nature Reviews Neurology 21.
Journal Article
38 (7), pp. 1127 - 1142 (2023)
Defining the riddle in order to solve it: There is more than one "Parkinson's Disease". Movement Disorders 22.
Journal Article
Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease. Journal of Neurochemistry, in press (2023)
23.
Journal Article
123 (14), pp. 9094 - 9138 (2023)
Targeting Biomolecular Condensation and Protein Aggregation against Cancer. Chemical Reviews 24.
Journal Article
13 (4), pp. 633 - 636 (2023)
People with early onset Parkinson’s disease: empowered to improve care. Journal of Parkinson's Disease: JPD 25.
Journal Article
29 (33), e202300649 (2023)
Chemical Synthesis of Alpha-Synuclein Proteins via Solid-Phase Peptide Synthesis and Native Chemical Ligation. Chemistry – A European Journal 26.
Journal Article
14, 1918 (2023)
Genipin prevents alpha-synuclein aggregation and toxicity by affecting endocytosis, metabolism and lipid storage. Nature Communications 27.
Journal Article
13 (2), pp. 179 - 196 (2023)
miR-101a-3p Impairs Synaptic Plasticity and Contributes to Synucleinopathy. Journal of Parkinson's Disease: JPD 28.
Journal Article
23, 174 (2023)
Glycosylation spectral signatures for glioma grade discrimination using Raman spectroscopy. BMC Cancer 29.
Journal Article
177, 105995 (2023)
The immune system in Parkinson's disease: From biology to diagnosis and therapeutic targets. Neurobiology of Disease 30.
Journal Article
11 (8), 2209 (2023)
Genome-Wide Expression Profile in People with Optic Neuritis Associated with Multiple Sclerosis. Biomedicines 31.
Journal Article
11 (2), 505 (2023)
Stem Cell Therapies in Movement Disorders: Lessons from Clinical Trials. Biomedicines 32.
Journal Article
38 (2), pp. 162 - 177 (2022)
Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts. Movement Disorders 33.
Journal Article
12, pp. 2397 - 2422 (2022)
Molecular Mechanisms Mediating the Transfer of Disease-Associated Proteins and Effects on Neuronal Activity. Journal of Parkinson's Disease: JPD 34.
Journal Article
11 (22), 3673 (2022)
Mutation of Tyrosine Sites in the Human Alpha-Synuclein Gene Induces Neurotoxicity in Transgenic Mice with Soluble Alpha-Synuclein Oligomer Formation. Cells 35.
Journal Article
269, 104721 (2022)
Ectosomes and exosomes modulate neuronal spontaneous activity. Journal of Proteomics 36.
Journal Article
Hexokinase 2: The preferential target of trehalose-6-phosphate over hexokinase 1. Journal of Cellular Biochemistry (2022)
37.
Journal Article
10 (1), 98 (2022)
Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies. Acta Neuropathologica Communications 38.
Journal Article
168, 105696 (2022)
Extracellular alpha-synuclein: Sensors, receptors, and responses. Neurobiology of Disease 39.
Journal Article
7, 65 (2021)
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease. NPJ Parkinsons Disease 40.
Journal Article
87, pp. 70 - 85 (2021)
JM-20 treatment prevents neuronal damage and memory impairment induced by aluminum chloride in rats. NeuroToxicology 41.
Journal Article
Molecular characterization of an aggregation-prone variant of alpha-synuclein used to model synucleinopathies. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2020)
42.
Journal Article
404, pp. 58 - 71 (2020)
Tapentadol Prevent Motor Impairments in a Mouse Model of Dyskinesia. Neuroscience 43.
Journal Article
116 (51), pp. 25991 - 2600 (2019)
Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1. Proceedings of the National Academy of Sciences of the United States of America 44.
Journal Article
28, pp. 65 - 77 (2019)
Cytosolic trapping of a mitochondrial heat shock protein is an early pathological event in synucleinopathies. Cell Reports 45.
Journal Article
47, pp. 909 - 918 (2019)
Investigating targets for neuropharmacological intervention by molecular dynamics simulations. Biochemical Society Transactions 46.
Journal Article
8, 18 (2019)
Dihydromyricetin and salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy. Translational neurodegeneration 47.
Journal Article
47 (3), pp. 827 - 838 (2019)
LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders? Biochemical Society Transactions 48.
Journal Article
85 (5), pp. 691 - 703 (2019)
Seeding variability of different alpha synuclein strains in synucleinopathies. Annals of Neurology 49.
Journal Article
12, 107 (2019)
Spreading of α-synuclein and tau: a systematic comparison of the mechanisms involved. Frontiers in Molecular Neuroscience 50.
Journal Article
22, 101135 (2019)
Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity. Redox Biology